A X bstract. The highly polyunsaturated fatty acids in fish oils lower the plasma triglyceride concentration. We have studied the effect of a diet rich in fish oil on the rate of production of the triglyceride-transporting very low density lipoprotein (VLDL). Seven subjects, five normal and two with hypertriglyceridemia received up to 30% of daily energy needs from a fish oil preparation that was rich in eicosapentaenoic acid and docosahexaenoic acid, w-3 fatty acids with five and six double bonds, respectively.
Introduction
The fatty acids of fish oils are quite different from those of most land animals and vegetable oils. Marine fatty acids, especially from cold waters, are rich in polyunsaturated fatty acids (PUFA)' of the w-3 series (the first double bond at the 3-carbon position from the methyl end) and contain up to six double bonds (1) . By contrast, vegetable oils tend to be rich in linoleic acid (w-6, two double bonds). For example, cod oil contains 51% of its fatty acid as w-3, whereas corn oil contains 57% as w-6.
Recent studies of men eating marine PUFA have shown a striking reduction in their plasma lipids, especially in triglyceride within very low density lipoproteins (VLDL) (2) (3) (4) . Rapid and substantial lowering of plasma triglyceride is achieved in patients with severe hypertriglyceridemia.
The mechanism for this profound lipid-lowering effect is unknown, and though the effect is greater with marine than 1. Abbreviations used in this paper: FCR, irreversible fractional removal rate; FFA, free fatty acid; HDL, IDL, LDL, and VLDL, high, intermediate, low, and very low density lipoproteins; PUFA, polyunsaturated with vegetable oil PUFA, it is possible that the modes of action are similar. Linoleic acid-rich oils have been reported to reduce the production and increase the clearance of VLDL in man (5) (6) (7) . Isolated rat hepatocytes (8) and perfused rat livers (9) esterify relatively less linoleic acid than unsaturated fatty acids of similar carbon chain length; this might reflect a diversion of fatty acid metabolism from triglyceride formation to other pathways, such as oxidation and ketogenesis. This paper presents measurements of VLDL apoprotein B and triglyceride transport in subjects eating diets enriched with either safflower oil or marine oil. The experiments were designed to determine the major mechanism responsible for the fish-oil induced lowering of plasma triglyceride in man.
Methods
Lipoprotein transport studies were carried out in seven subjects, five healthy young men who volunteered and two hyperlipidemic patients (Table I) . Four others took part in studies of free fatty acid (FFA) transport. The normolipidemic subjects were studied on the metabolic ward. One hyperlipidemic patient was an inpatient (subject 5), the other a closely supervised outpatient (subject 6); they were provided with the oil supplements and kept diaries of food intake. The lipid-lowering drug, clofibrate, was stopped 5 wk before the studies began on subject 5.
In the lipoprotein transport studies (subjects 1-7) the dietary comparison was between fish oil and safflower oil. Each diet was from 2 to 3.5 wk long, enough time to induce new steady plasma triglyceride and cholesterol concentrations, based on values during the last 5 d of each study. Dietary details are shown in Table II (12) . The lipoprotein was sterilized, tested to be pyrogen-free, and reinjected gCi total radioactivity). Potassium iodide, 180 mg daily, was given before and after the injection to reduce thyroidcal uptake of radioiodine.
Samples of blood were taken between 10 min and 48 h after reinjection for measurement of apoprotein B specific radioactivity in reisolated lipoproteins; VLDL (Sf, 20-400), intermediate density lipoprotein (IDL) (Sf, (12) (13) (14) (15) (16) (17) (18) (19) (20) , and low density lipoprotein (LDL) (Sf, 0-12) were obtained by sequential ultracentrifugation in the 50 Ti anglehead rotor. Apoprotein B was precipitated with isopropanol and assayed for radioactivity and mass (13) . The specific radioactivity-time curves of VLDL apoprotein B when plotted semilogarithmically were resolved into two exponentials in all studies except in subject 5 during the first (safflower oil) study. The latter specific radioactivity-time curve appeared monoexponential over 48 h. * Cholesterol content of fish oil was 3.6 mg/g and was balanced during alternate diet by egg yolk. $ Ratio of polyunsaturated (P) (w-3 + w-6)
to saturated (S) fatty acids. § Percent of total fat by weight as safflower oil (SO) or fish oil (FO). The oil was given in three equal amounts each day. II Percent of total fat by weight as w-6 or w-3 fatty acid.
The transport of apoprotein B in VLDL was calculated by conventional one-and two-pool analysis. For the single monoexponential curve, the irreversible fractional removal rate was calculated as 0.693/tI/2 (14) .
For the remaining curves, the irreversible fractional removal rate was calculated as (a * #)/KBA, where a and ft are the exponentials describing loss of radioactivity from the rapid and slowly exchanging compartments A and B, respectively, and KBA is the fractional rate oftransfer of material from pool B to A. KBA = a + f3 + KS,. (KA, is the fractional removal rate from pool A both to pool B and irreversibly from the system, KAA = -(a CA + ,. CB)/(CA + CB), where CA and CB are the respective zero-time intercepts for a and 1s.) (15) Transport was calculated by multiplying the irreversible fractional removal rate by the pool size, measured as the amount of VLDL apoprotein B in plasma (plasma = 4.5% body mass). The mass of protein in pool A, the rapidly exchanging compartment, was calculated separately from the dilution of the injected radioactivity as radioactivity injected/ (CA + CB) (reference 15) . Apoprotein B was assayed as the isopropanol precipitable protein by the Lowry method (13) using bovine albumin as the standard, without correcting for chromogenicity differences.
VLDL triglyceride kinetics. During the final 2 d, when the triglyceride and apoprotein B kinetics were carried out, only carbohydrate (90% of energy) and protein were eaten. This ensured that only small variations in VLDL triglyceride concentration occurred (mostly ±5% ofthe average in the first six samples taken during the mhorning after the radioglycerol injection). This value was taken to represent the VLDL triglyceride concentration due to each treatment. The total energy consumed daily during the kinetic studies was -85% of that eaten previously. 200 iMCi of [2-3H~glycerol (The Radiochemical Centre Ltd., Amer- sham, England) was injected together with '251-VLDL (except in subject 7) on the morning after the subject had fasted overnight. Samples of blood were initially taken every hour for S h and then less frequently, for a total of 48 h. Lunch, dinner, and supper (containing minimal fat) were then eaten at the usual times.
Lipoproteins (VLDL) were isolated from plasma by ultracentrifugation as described. Aliquots of VLDL were extracted with 30 vol isopropanol, and phospholipids were removed by adsorption onto alumina. A portion ofthe extract was used to determine triglyceride concentration by the Neri and Frings (16) method. The remainder of the extract was evaporated and dissolved into scintillation fluid (Instagel; Packard Instrument Co., Melbourne) for analysis of radioactivity.
The specific activity-time curves were analyzed as described by Zech et al. (17) through linear first-order compartmental modeling. The incorporation of glycerol into triglyceride assumes two hepatic pathways, one being faster than the other, followed by a series of delipidation steps ofplasma VLDL. Compartmental modeling was essential for these studies to take into account the incorporation of glycerol into triglyceride in the liver and the secretion and delipidation of VLDL. The apoprotein B data could be analyzed more simply, since they represented only the removal, through delipidation, of VLDL.
FFA flux. In four additional normotriglyceridemic healthy subjects, we compared the transport of eicosapentaenoic acid with that of oleic acid, the major plasma FFA. This was carried out after 7 d ofa MaxEPArich diet (20% of energy), as described above. This was enough time to raise plasma eicosapentaenoic acid levels to concentrations that could be measured accurately and to lower plasma triglyceride and VLDL concentrations substantially in normal subjects. Flux rates were determined during constant infusions of the radiolabeled FFA. [9-3H] (Table V) . Although the reduction in pool size was largely explicable in terms of reduced transport (presumably reflecting reduced secretion of VLDL), the irreversible fractional removal rate tended to fall in the two hyperlipidemic subjects (5 and 6), in contrast with the rise in the four normolipidemic men (subjects 1-4).
Dietary fish oil altered the relationship between the apo- Table  VI . In every subject, the substantial fall in VLDL triglyceride concentration was accompanied by a striking reduction in flux. As with the apoprotein B studies, the changes (reductions) in flux were far greater than the changes (rises) in fractional removal rate, confirming that diminished production was the major cause for the hypotriglyceridemic effect of the fish oil.
Free fatty acid flux. The plasma total FFA concentrations were in the normal range (21, 22), contrasting with the very low plasma triglyceride levels (Table VII) . The total flux of plasma FFA can also be estimated on the assumption that oleic acid represents average FFA transport. Since the mean flux of oleic acid in the four subjects was 155 1M/min and constituted about one quarter of the plasma FFA mass, the approximate total FFA flux was on the order of 620 AM/min which is in the reported normal range (21, 22). The flux of eicosapentaenoic acid was high relative to its concentration; whereas the concentration of eicosapentaenoic acid was, on the average, 8% of that of oleic acid, its flux averaged 19% of that of oleate.
Discussion
Effects on lipid and lipoprotein concentrations. This study has confirmed the substantial triglyceride-lowering effect of w-3 PUFA (2-4). The magnitude appeared to be dose related, being greatest in subjects who received 29% of energy needs from the fish oil. Whereas total cholesterol levels in plasma were also reduced, this reduction was smaller and reflected the various changes in lipoproteins. Two points may be worth noting. First, the normolipidemic subjects showed habitual plasma cholesterol (27, 28) . The cholesterol content of our batch of fish oil was 364 mg/100 g. The mechanism for the reduction in HDL, at least with w-6, has been attributed to diminished synthesis, since the fractional removal rate is unaltered (26) .
The effect of w-3 PUFA on LDL was variable and clearly differed from that induced by w-6 PUFA, which generally lower LDL (23, 24) . In fact, LDL cholesterol and apoprotein B rose Table IV , does not include three unusual fatty acids that accounted for 7% of the total but were present in trace amounts at most in the plasma (provisionally identified as 20:1 w-9, 18:4 w-3, and 22:1 w-1 1). The major fatty acid of safflower oil is linoleic acid (67% in the oil used in these studies). As expected, the long-chain w-3 PUFA of the fish oil were reflected in the plasmas at the expense of linoleic (w-6) and oleic (w-9) acids. This has been reported previously by BronsgeestSchoute et al. (29) and by Harris et al. (3) .
VLDL apoprotein B and triglyceride kinetics. The striking reduction in daily flux or transport of apoprotein B in VLDL is clearly the major reason for the marked reduction in VLDL triglyceride and apoprotein B, being as much as 84% in subject 2.
The reduced VLDL apoprotein B pool size was accompanied by an increased irreversible fractional removal rate (FCR) in the four normolipidemic men (Table V) . The most likely explanation is that the rise in FCR reflected merely the smaller pool rather than a primary effect on removal, since the FCR in the hypertriglyceridemic subjects was little altered. This was confirmed by the even more substantial falls in triglyceride formation in each ofthe five subjects. Again, changes in FCR were much less than in flux, indicating that the predominant effect of fish oil is on production.
Reduced formation has been put forward to explain the triglyceride lowering effect on w-6 PUFA. Nestel (Fig. 1) . However, in two subjects the relationship between IDL and LDL curves was unusual with the fish oil diet. One conventional explanation for the peaking of the LDL apoprotein B specific radioactivity well before its intersection with the IDL curve is that there is substantial independent secretion of LDL-like particles; this was observed especially in subject 2. Similar findings have been reported with familial hypercholesterolemia (31) and this secretion occurs normally in the rat (32) . This may reflect the paucity of secreted triglyceride, leading to the secretion of lipid-poor particles with the density of LDL. FFA kinetics. (8, 9) . We have recently found significantly higher rates of fatty acid oxidation and ketogenesis and lower rates of lipogenesis in livers from MaxEPAfed than from safflower oil-fed rats (33) . Further, less VLDL was secreted from the perfused livers of MaxEPA-fed rats (33) .
In studies with isolated hepatocytes, less [3Hjglycerol was incorporated into hepatic triglyceride and less labeled triglyceride was secreted from hepatocytes of fish oil-fed than of safflower oil-fed rats (Wong, S., and P. J. Nestel, unpublished observation). These data in the rat support our findings in man of a primary reduction in triglyceride production in the liver, which may in part reflect diversion of polyenoic fatty acids to pathways of oxidation and ketogenesis. However 
